Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 3452898, 4 pages
http://dx.doi.org/10.1155/2016/3452898
Research Article

Estimation of the Relative Contribution of Postprandial Glucose Exposure to Average Total Glucose Exposure in Subjects with Type 2 Diabetes

1Lund University, 22184 Lund, Sweden
2Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936-1080, USA

Received 18 April 2016; Accepted 28 July 2016

Academic Editor: Małgorzata Kotula-Balak

Copyright © 2016 Bo Ahrén and James E. Foley. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Nathan, D. E. Singer, K. Hurxthal, and J. D. Goodson, “The clinical information value of the glycosylated hemoglobin assay,” The New England Journal of Medicine, vol. 310, no. 6, pp. 341–346, 1984. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Monnier, C. Colette, and D. R. Owens, “Postprandial and basal glucose in type 2 diabetes: assessment and respective impacts,” Diabetes Technology & Therapeutics, vol. 13, no. 2, pp. S25–S32, 2011. View at Google Scholar · View at Scopus
  3. E. Bonora, “Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives,” International Journal of Clinical Practice, Supplement, vol. 129, pp. 5–11, 2002. View at Google Scholar · View at Scopus
  4. J. H. DeVries, “Glucose variability: where it is important and how to measure it,” Diabetes, vol. 62, no. 5, pp. 1405–1408, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Ghio, G. Seghieri, C. Lencioni et al., “1-Hour OGTT plasma glucose as a marker of progressive deterioration of insulin secretion and action in pregnant women,” International Journal of Endocrinology, vol. 2012, Article ID 460509, 5 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Tura, J. Farngren, A. Schweizer, J. E. Foley, G. Pacini, and B. Ahrén, “Four-point preprandial self-monitoring of blood glucose for the assessment of glycemic control and variability in patients with type 2 diabetes treated with insulin and vildagliptin,” International Journal of Endocrinology, vol. 2015, Article ID 484231, 7 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. E. B. Ketema and K. T. Kibret, “Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis,” Archives of Public Health, vol. 73, article 43, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. D. M. Nathan, J. Kuenen, R. Borg, H. Zheng, D. Schoenfeld, and R. J. Heine, “Translating the A1C assay into estimated average glucose values,” Diabetes Care, vol. 31, no. 8, pp. 1473–1478, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. B. Ahrén, M. Landin-Olsson, P.-A. Jansson, M. Svensson, D. Holmes, and A. Schweizer, “Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes,” The Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 5, pp. 2078–2084, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Bosi, R. P. Camisasca, C. Collober, E. Rochotte, and A. J. Garber, “Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin,” Diabetes Care, vol. 30, no. 4, pp. 890–895, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. H. An and L. He, “Current understanding of metformin effect on the control of hyperglycemia in diabetes,” Journal of Endocrinology, vol. 228, pp. R97–R106, 2016. View at Publisher · View at Google Scholar
  12. A. Lee and J. E. Morley, “Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes,” Obesity Research, vol. 6, no. 1, pp. 47–53, 1998. View at Publisher · View at Google Scholar · View at Scopus
  13. M. N. Munshi, A. R. Segal, C. Slyne, A. A. Samur, K. M. Brooks, and E. S. Horton, “Shortfalls of the use of HbA1C-derived eAG in older adults with diabetes,” Diabetes Research and Clinical Practice, vol. 110, pp. 60–65, 2015. View at Publisher · View at Google Scholar · View at Scopus